section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

F and E: hyperkalemia

GI: diarrhea, nausea

Neuro: dizziness, gait disturbances, headache, mental status changes, sedation

Interactions

Drug-drug:

Availability

Route/Dosage

Dose should be based on target dry body weight.

US Brand Names

Korsuva

Action

  • Acts as a kappa opioid agonist. Mechanism for effectiveness in pruritus unknown.
Therapeutic effects:
  • Reduced severity of itching.

Classifications

Therapeutic Classification: none assigned

Pharmacologic Classification: opioid agonists

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Well distributed to tissues.

Metabolism/Excretion: Not metabolized by CYP450 isoenzymes. Primarily excreted in feces (59%), with 20% excreted into dialysate fluid, and 11% excreted in urine.

Half-Life: 23–31 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
IVrapidend of infusionunknown



Patient/Family Teaching

Pronunciation

dye-FEL-i-KEF-a-lin